Article

Breaking Down the Acne Management Timeline: Clinical Considerations and Challenges (2008;82[suppl 2{i}]:1-25)[erratum]

Funding for the peer-reviewed publication was provided by Dermik Laboratories, a business unit of sanofi-aventis US LLC.

Cutis. 2008 December;82(6):425
PDF Download

 

Recommended Reading

Acne Treatments Reviewed, Starting With Touch
MDedge Dermatology
Superficial Chemical Peels and Microdermabrasion for Acne Vulgaris
MDedge Dermatology
Evidence for Laser- and Light-Based Treatment of Acne Vulgaris
MDedge Dermatology
A Combined Oral Contraceptive Containing 3-mg Drospirenone/20-µg Ethinyl Estradiol in the Treatment of Acne Vulgaris: A Randomized, Double-blind, Placebo-Controlled Study Evaluating Lesion Counts and Participant Self-assessment
MDedge Dermatology
Levonorgestrel-Releasing Intrauterine System and New-Onset Acne [letter]
MDedge Dermatology
The Effect of Vehicle Formulation on Acne Medication Tolerability
MDedge Dermatology
Benzoyl Peroxide Cleansers for the Treatment of Acne Vulgaris: Status Report on Available Data
MDedge Dermatology
Safety of a Novel Gel Formulation of Clindamycin Phosphate 1.2%–Tretinoin 0.025%: Results From a 52-Week Open-Label Study
MDedge Dermatology
Acne and Rosacea: Who and Where Are the Experts? [editorial]
MDedge Dermatology
Clinical Implications of Minocycline Use in Acne Vulgaris: Focus on Antimicrobial and Anti-inflammatory Properties
MDedge Dermatology